Moderna launches mRNA bird flu vaccine trial
Digest more
A recent clinical trial using an mRNA vaccine helped to greatly extend the lives of people with pancreatic cancer and a new ...
CureVac has filed a lawsuit in Delaware federal court accusing Moderna of infringing eight U.S. patents tied to mRNA stabilization technology in its COVID-19 vaccine Spikevax. The case is part of ...
German biotech firm CureVac has filed a lawsuit against Moderna in Delaware, alleging patent infringement of its mRNA technology in Moderna's COVID-19 vaccine, Spikevax. The case is among several ...
Add Yahoo as a preferred source to see more of our stories on Google. The United States is turning its back on what could be the greatest medical advance in a generation — vaccines made with messenger ...
Messenger RNA technology, better known as mRNA technology, made it possible to rapidly deploy a new vaccine during the COVID-19 pandemic — much earlier than would otherwise have been possible, ...
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), a biotechnology company focused on gene therapies for age-related ...
Dr. Elias Sayour says the mRNA vaccine is helping shed new light on cancer treatments. “There have been patients that have ...
EDITOR’S NOTE: The views expressed in this commentary are solely those of the writer. CNN is showcasing the work of The Conversation, a collaboration between journalists and academics to provide news ...
Investing.com - German biotech company CureVac sued Moderna (NASDAQ:MRNA) in Delaware federal court on Friday, alleging that Moderna’s COVID-19 vaccine Spikevax infringed CureVac patents related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results